You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
At Astellas, we are driving a pipeline of transformative therapies, focusing on new targets with cutting-edge modalities. Our R&D strategy is guided by a Focus Area Approach which combines a deep understanding of disease biology and the use of innovative technology platforms and versatile treatment modalities to tackle diseases with high unmet medical needs. This approach enables us to focus our resources on four Primary Focuses where we have strong, differentiated capabilities: Blindness and Regeneration, Genetic Regulation, Immuno-Oncology, and Targeted Protein Degradation.
Visit our Partnering page to learn about opportunities to collaborate.